When was Watchmaker Genomics founded?

Watchmaker Genomics was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Where is Watchmaker Genomics located?

Watchmaker Genomics is headquartered in Boulder, United States.

How many employees does Watchmaker Genomics have?

As of Sep 30, 2026, the latest employee count at Watchmaker Genomics is 277.

Is Watchmaker Genomics a funded company?

Watchmaker Genomics is a funded company, having raised a total of $48.3M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 04, 2020.

When was the latest funding round of Watchmaker Genomics?

Watchmaker Genomics' latest funding was a $***** Series A round on Jun 02, 2022, with participation from 2 investors.

Where does Watchmaker Genomics rank among its competitors?

Watchmaker Genomics ranks 25th amongst 2139 active competitors, of which 497 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was eGenesis, which secured $14M in Aug, 2026.

Who are the top competitors of Watchmaker Genomics?

Watchmaker Genomics' top competitors include Beam Therapeutics, Antheia and Transcenta. Among them, eGenesis secured the most recent funding round in August, 2026.

Watchmaker Genomics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of gene-editing technology. It is developing protein engineering with enzyme manufacturing technology which is used for genomic technology. It offers high-performance enzymes and kits used in next-generation sequencing (NGS) and other molecular biology research applications.

Website: www.watchmakergenomics.com/
Email ID: *****@watchmakergenomics.com

Key Metrics

Founded Year

2018

Location

Boulder, United States

Stage

Series A

Total Funding

$48.3M in 2 rounds

Latest Funding Round

Series A, Jun 02, 2022, $*****

Investors

Decheng Capital & 1 more

Ranked

25^th among 2139 active competitors

Employee Count

277 as on Sep 30, 2026

Similar Companies

Beam Therapeutics & 2856 more

View Watchmaker Genomics' full profile

Watchmaker Genomics has raised a total funding of $48.3M over 2 rounds. Its first funding round was on Dec 04, 2020. Its latest funding round was a Series A round on Jun 02, 2022 for $*****. 2 investors participated in its latest round. Watchmaker Genomics has 2 institutional investors.

Here is the list of recent funding rounds of Watchmaker Genomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 02, 2022	5724481	Series A	3796553	7042268	1563339	2214769
Dec 04, 2020	4706492	Seed	4335976	1517357	4452704	5125708

Access funding benchmarks and valuations. Sign up today!

View details of Watchmaker Genomics's funding rounds and investors

The founders of Watchmaker Genomics are Brian Kudlow and Stephen Picone.

Here are the details of Watchmaker Genomics' key team members:

Brian Kudlow: Co-Founder of Watchmaker Genomics.
Contact Info: 1 email address
Stephen Picone: Co-Founder & CSO of Watchmaker Genomics.
Contact Info: 1 email address

View details of Watchmaker Genomics's Founder profiles and Board Members

Watchmaker Genomics' employee count trend

Watchmaker Genomics has 277 employees as of Sep 26. Here is Watchmaker Genomics's employee count trend over the years:

Employee count trend for Watchmaker Genomics

Uncover Watchmaker Genomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Watchmaker Genomics include Beam Therapeutics, Antheia and Transcenta. Here is the list of Top 10 competitors of Watchmaker Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Beam Therapeutics 2017, Cambridge (United States), Public	Developer of gene therapy using CRISPR base editing to treat diseases	$222M	Redmile Group, Cormorant-asset & 16 others	71/100
2nd	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
3rd	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
4th	eGenesis 2015, Cambridge (United States), Series D	Developer of a gene transplantation platform for humanizing pig cells	$495M	Monashee Investment Management, Farallon Capital Management ... & 31 others	65/100
5th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Loayal Valley Capital, Sino Biopharmaceutical ... & 18 others	65/100
6th	Mammoth 2017, Brisbane (United States), Series D	Provider of molecular diagnostics platform by using CRISPR technology	$271M	Redmile Group, Decheng Capital & 34 others	65/100
7th	Scribe Therapeutics 2018, Alameda (United States), Public	Developer of a gene-editing platform using CRISPR technology	$120M	Avoro Capital, Andreessen Horowitz & 7 others	65/100
8th	Metagenomi 2016, Berkeley (United States), Public	Digital gene editing technologies for drug development	$376M	Humboldt Fund, RA Capital Management & 22 others	65/100
9th	Locus Biosciences 2015, Raleigh (United States), Series B	Developer of therapeutics for infectious disease and inflammatory indications	$67.3M	Artis Ventures, Illumina & 13 others	64/100
10th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Cormorant Asset Management, Atlas Venture ... & 14 others	64/100
25th	Watchmaker Genomics 2018, Boulder (United States), Series A	Developer of gene-editing technology	$48.3M	Decheng Capital, Eclipse	63/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Watchmaker Genomics's competitors? Click here to see the top ones

Watchmaker Genomics has made no investments or acquisitions yet.

Here is the latest report on Watchmaker Genomics's sector:

Free

Internet of Things - Sector Report

Edition: August, 2026 (80 Pages)

View all reports related to Watchmaker Genomics

Media has covered Watchmaker Genomics for a total of 13 events in the last 1 year, 6 of them have been about company updates and 5 about partnerships.